HIV doula support for pregnant and new mothers
Part of Infections, Women’s health & pregnancy clinical trials.
This program provides doula support—a trained companion who offers emotional, physical, and educational help during pregnancy and after birth—for women living with HIV. It aims to support you through your pregnancy and postpartum journey with extra care and guidance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are pregnant now or have just had a baby (postnatal)
- You have been diagnosed with HIV
- You live in South Florida
- You can read, write, and understand English, Spanish, or Haitian Creole at a 6th-grade level
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking omega-3 supplements can improve pregnancy outcomes and reduce inflammation in pregnant women living with HIV who are on antiretroviral therapy. If you are between 20 and 29 weeks pregnant with a single baby, you may be eligible to join.
This study tests a program where trained 'mentor mothers' provide extra support to pregnant and postpartum women living with HIV and their babies. It aims to help women stay healthy and engaged in care.
This study tests a program to reduce stigma related to HIV among pregnant women and new mothers. You may be eligible if you are living with HIV, are between 24 and 36 weeks pregnant, and plan to stay in the area for at least 6 months after your baby is born.
This study looks at how being pregnant while living with HIV affects your quality of life and the care you receive. It aims to understand your experiences and needs during this time.
This study offers doula support to families whose newborn is in the NICU for at least 2 weeks. It aims to help parents feel more supported and less stressed during this difficult time.
This study tests a two-drug HIV treatment combination (dolutegravir and lamivudine) for pregnant women who have never taken HIV medicine before. The goal is to see if this combination safely controls HIV during pregnancy and protects the baby.
Hear when a new Pregnant HIV Positive Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.